SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Themis Medicare informs about updates

17 Oct 2025 Evaluate

Themis Medicare has informed that in accordance with SEBI Circular No. SEBI/HO/MIRSD/MIRSD-PoD/P/CIR/2025/97 dated July 02, 2025 in respect of ‘Ease of Doing Investment - Special Window for Re-lodgement of Transfer Requests of Physical Shares’, it enclosed the Report on shares relodged for transfer-cum-demat in the format prescribed in Annexure-A of the said circular, for the months of July, August and September 30, 2025. As confirmed by its RTA, MUFG Intime India, no case for re-lodgement of transfer request of physical shares have been received for the months of July, August and September 30, 2025.

The above information is a part of company’s filings submitted to BSE.

Themis Medicare Share Price

118.45 -0.70 (-0.59%)
03-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1904.65
Dr. Reddys Labs. 1374.55
Cipla 1458.45
Zydus Lifesciences 1141.00
Lupin 2476.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: